Pfizer, Anti-DEI Group End Suit Over Diversity Fellowship

Pfizer Inc. and a conservative group agreed to end litigation challenging the legality of the company’s multi-year Breakthrough Fellowship Program designed to build a diverse pipeline of scientific talent.

Attorneys for the pharmaceutical giant and plaintiff conservative advocacy group Do No Harm made the announcement in a joint stipulation of dismissal filed with the US District Court for the Southern District of New York on Friday.

Read more in Bloomberg Law.